Table 2.
Correlation Between LNR/LNC and Clinical Pathology Characteristics in Germ Cell and Trophoblastic Tumors.
Variable | LNR | χ2 | P Value | LNC | χ2 | P Value | ||
---|---|---|---|---|---|---|---|---|
≤0.1538 | >0.1538 | 0-2 | >2 | |||||
Age | ||||||||
≤27 | 407 (85.3%) | 70 (14.7%) | 0.750 | 0.386 | 391 (82.0%) | 86 (18.0%) | 0.489 | 0.484 |
>27 | 378 (83.3%) | 76 (16.7%) | 380 (83.7%) | 74 (16.3%) | ||||
Martial status | ||||||||
Married | 257 (86.0%) | 42 (14.0%) | 5.583 | 0.134 | 253 (84.6%) | 46 (15.4%) | 3.982 | 0.263 |
Single | 468 (82.5%) | 99 (17.5%) | 460 (81.1%) | 107 (18.9%) | ||||
Unknown | 25 (96.2%) | 1 (3.8%) | 24 (92.3%) | 2 (7.7%) | ||||
Separated/Divorced/Widowed | 35 (89.7%) | 4 (10.3%) | 34 (87.2%) | 5 (12.8%) | ||||
Race | ||||||||
White | 723 (84.6%) | 132 (15.4%) | 0.470 | 0.493 | 708 (82.8%) | 147 (17.2%) | <0.001 | 0.985 |
Other | 62 (81.6%) | 14 (18.4%) | 63 (82.9%) | 13 (17.1%) | ||||
Tumor size | ||||||||
≤4 cm | 443 (87.4%) | 64 (12.6%) | 7.877 | 0.005 | 426 (84.0%) | 81 (16.0%) | 1.144 | 0.285 |
>4 cm | 342 (80.7%) | 82 (19.3%) | 345 (81.4%) | 79 (18.6%) | ||||
T stage | ||||||||
T0/T1 | 447 (86.5%) | 70 (13.5%) | 13.195 | 0.004 | 445 (86.1%) | 72 (13.9%) | 8.799 | 0.032 |
T1 | 267 (84.0%) | 51 (16.0%) | 250 (78.6%) | 68 (21.4%) | ||||
T3/T4 | 61 (77.2%) | 18 (22.8%) | 63 (79.7%) | 16 (20.3%) | ||||
TX | 10 (58.8%) | 7 (41.2%) | 13 (76.5%) | 4 (23.5%) | ||||
N stage | ||||||||
N0/N1 | 557 (92.5%) | 45 (7.5%) | 86.775 | <0.001 | 546 (90.7%) | 56 (9.3%) | 74.390 | <0.001 |
N2/N3 | 228 (69.3%) | 101 (30.7%) | 225 (68.4%) | 104 (31.6%) | ||||
M stage | ||||||||
M0 | 664 (86.8%) | 101 (13.2%) | 19.948 | <0.001 | 641 (83.8%) | 124 (16.2%) | 2.876 | 0.090 |
M1 | 121 (72.9%) | 45 (27.1%) | 130 (78.3%) | 36 (21.7%) | ||||
7th AJCC stage | ||||||||
I | 336 (100.0%) | 0 (0.0%) | 103.074 | <0.001 | 336 (100.0%) | 0 (0.0%) | 111.759 | <0.001 |
II | 304 (77.9%) | 86 (22.1%) | 278 (71.3%) | 112 (28.7%) | ||||
III | 145 (70.7%) | 60 (29.3%) | 157 (76.6%) | 48 (23.4%) | ||||
Histology | ||||||||
Germ cell neoplasms | 757 (84.0%) | 144 (16.0%) | 1.905 | 0.167 | 745 (82.7%) | 156 (17.3%) | 0.323 | 0.570 |
Trophoblastic neoplasms | 28 (93.3%) | 2 (6.7%) | 26 (86.7%) | 4 (13.3%) | ||||
Lymph-vascular Invasion | ||||||||
Unknown | 98 (87.5%) | 14 (12.5%) | 3.264 | 0.196 | 94 (83.9%) | 18 (16.1%) | 1.129 | 0.569 |
Negative | 392 (85.6%) | 66 (14.4%) | 384 (83.8%) | 74 (16.2%) | ||||
Positive | 295 (81.7%) | 66 (18.3%) | 293 (81.2%) | 68 (18.8%) | ||||
Primary site | ||||||||
Testis, NOS | 376 (83.4%) | 75 (16.6%) | 0.594 | 0.441 | 379 (84.0%) | 72 (16.0%) | 0.917 | 0.338 |
Descended testis | 409 (85.2%) | 71 (14.8%) | 392 (81.7%) | 88 (18.3%) |